香港成人接种肺炎球菌疫苗意愿的相关因素:基于健康信念模型构建的横断面研究
该研究于2024年12月至2025年2月在香港18-64岁有肺炎球菌感染风险条件者及65岁及以上成人中开展全港横断面调查,采用便利抽样从网络广告招募1020人。73.8%(753人)表示愿意在未来12个月内接种肺炎球菌疫苗;自评健康者意愿较低,吸烟、既往流感疫苗接种、对单剂疫苗接受度高及健康信念模型各维度得分较高者意愿较高。
要点
- 1020名参与者中73.8%(753人)愿意在未来12个月内接种肺炎球菌疫苗。
- 自评健康者接种意愿较低(AOR 0.538,95%CI 0.322-0.898,p=0.018)。
- 吸烟、既往流感疫苗接种及对单剂疫苗接受度高与接种意愿较高相关。
核心结论
- 研究识别了影响肺炎球菌疫苗接种意愿的关键因素,尤其是与健康信念模型相关的因素;针对这些因素的定向公共卫生干预可能提高疫苗接种率。
- 作者认为进一步研究可采用纵向设计追踪疫苗意愿变化并评估定向干预的效果。
研究设计与样本
- 于2024年12月至2025年2月在香港开展的全港横断面调查,采用便利抽样从网络广告招募18-64岁有肺炎球菌感染风险条件者及65岁及以上成人,共纳入1020名参与者(男580名,女440名;39.9%年龄在50-64岁)。
- 收集社会人口学特征、健康信念模型(HBM)构建、疫苗知识和卫生系统信任度数据,采用逻辑回归分析识别与肺炎球菌疫苗接种意愿相关的因素。
主要发现
- 73.8%(n=753)的参与者表示愿意在未来12个月内接种肺炎球菌疫苗。
- 自评健康者报告愿意接种的可能性较低(AOR 0.538,95%CI 0.322-0.898,p=0.018)。
- 吸烟者(AOR 2.184,95%CI 1.314-3.630,p=0.003)和既往接种流感疫苗者(AOR 3.155,95%CI 2.040-4.878,p<0.001)报告愿意接种的可能性较高。
- 对单剂疫苗接受度较高与接种意愿较高相关(AOR 3.582,95%CI 2.404-5.338,p<0.001)。
- 自我效能水平较高(AOR 5.882,95%CI 3.369-10.269,p<0.001)、感知肺炎球菌易感性(AOR 2.079,95%CI 1.249-3.459,p=0.005)、感知疫苗益处(AOR 3.920,95%CI 2.271-6.766,p<0.001)及行动提示(AOR 3.925,95%CI 2.400-6.417,p<0.001)较高者报告愿意接种的可能性较高。
临床怎么用
- 作者认为针对健康信念模型相关因素的定向公共卫生干预可能提高疫苗接种率,改善高风险人群保护和公共卫生结局。
- 作者建议进一步研究可采用纵向设计追踪疫苗意愿变化并评估定向干预效果。
局限性
- 原文未报告局限性。
- 原文在结论中提出进一步研究可采用纵向设计追踪疫苗意愿变化并评估定向干预效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Pneumococcal infections pose a significant global health risk, especially for elderly and immunocompromised populations. This study explores the willingness of Hong Kong adults aged 18-64 years with risk conditions of pneumococcal and aged 65 years or above to receive the pneumococcal vaccine and identifies the factors influencing this willingness. METHODS: A territory-wide cross-sectional survey was conducted between December 2024 and February 2025 among the Hong Kong adults aged 18-64 years with risk conditions of pneumococcal and aged 65 years or above. Convenience sampling was adopted and participant were recruited from online advertainments. Data were gathered on sociodemographic characteristics, Health Belief Model (HBM) constructs, vaccine knowledge, and trust in the healthcare system. Logistic regression analyses were used to identify factors associated with willingness to receive the pneumococcal vaccine. RESULTS: A total of 1020 participants (580 males, 440 females; 39.9 % aged 50-64 years) participated in the study. Of these, 73.8 % (n = 753) expressed a willingness to receive the pneumococcal vaccine within the next 12 months. Participants self-reported as healthy were less likely to report willingness (AOR, 95 % CI 0.538 [0.322-0.898], p = 0.018), while participants with smoking (AOR, 95 % CI 2.184 [1.314-3.630], p = 0.003) and prior flu vaccination (AOR, 95 % CI 3.155 [2.040-4.878], p < 0.001) were more likely to report willingness. Higher acceptance of a single-dose vaccine also correlated with greater willingness (AOR, 95 % CI 3.582 [2.404-5.338], p < 0.001). In addition, participant with higher level of self-efficacy (AOR, 95 % CI 5.882 [3.369-10.269], p < 0.001), perceived susceptibility to pneumococcus (AOR, 95 % CI 2.079 [1.249-3.459], p = 0.005), perceived vaccine benefits (AOR, 95 % CI 3.920 [2.271-6.766], p < 0.001), and cues to action (AOR, 95 % CI 3.925 [2.400-6.417], p < 0.001) were more likely to report willingness. CONCLUSIONS: This study identifies key factors influencing willingness to receive the pneumococcal vaccine, particularly those related to the HBM. Targeted public health interventions addressing these factors could increase vaccine uptake, improving protection for high-risk populations and enhancing public health outcomes. Further studies could employ longitudinal designs to track changes in vaccine intentions and evaluate the effectiveness of targeted interventions.
引用
- Zhong CC, Yang Z, Chen M, et al. Factors associated with willingness among adults to receive pneumococcal vaccine in Hong Kong: a cross-sectional study using HBM constructs. Vaccine. 2025. PMID: 40738002. doi:10.1016/j.vaccine.2025.127544
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。